Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

RespireRx Pharmaceuticals Inc. (CORX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.02.25.411.90.10.1
            Revenue growth    -100.0%-59.5%-54.4%13549.7%40.9%2998.8%
Cost of goods sold  0.00.00.00.00.00.0-7.7-7.5
Gross profit  0.00.00.02.25.411.97.77.6
            Gross margin     100.0%100.0%100.0%8905.0%12337.8%
Selling, general and administrative   [+]1.92.71.11.53.98.73.63.8
Research and development  0.70.60.60.71.53.21.70.6
Other operating expenses     2.24.28.57.77.5
EBITDA   [+]    -4.2-8.5-5.2-4.4
            EBITDA margin     -99.3%-78.4%-71.4%-6020.2%-7057.1%
Depreciation and amortization      0.00.00.00.0
EBIT   [+]-2.6-3.3-1.7-2.2-4.2-8.5-5.2-4.4
            EBIT margin     -99.3%-78.5%-71.4%-6028.4%-7059.7%
Interest expense, net   [+]0.70.50.40.10.10.60.90.1
Other income (expense), net   [+]0.1-0.40.0-0.30.1-0.20.21.8
Pre-tax income  -3.1-4.3-2.1-2.6-4.3-9.2-6.0-2.7
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -3.5-5.7-2.1-2.6-4.3-9.2-6.0-12.8
            Net margin     -118.3%-79.3%-77.8%-6867.3%-20705.3%
   
Basic EPS   [+]($0.04)($0.22)($5.41)($0.77)($1.77)($4.95)($5.05)($0.07)
Diluted EPS   [+]($0.04)($0.22)($5.41)($0.77)($1.77)($4.95)($5.05)($0.07)
   
Shares outstanding (basic)   [+]88.325.90.43.42.41.91.2192.7
Shares outstanding (diluted)   [+]88.325.90.43.42.41.91.2192.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy